Using CRISPR-Cas9 technology, human intestinal organoids were sequentially edited to introduce APC, TP53, KRAS, and SMAD4 mutations, successfully modeling the multistep progression of colorectal cancer (52). This evidence concerns the gene KRAS and colorectal cancer.